Site-specific pathology in breast reduction mammoplasty.
To investigate the feasibility and clinical value of site-specific pathology in breast reduction mammoplasty. Totally 127 patients who underwent breast reduction mammoplasty from June 2007 to June 2010 were included. Pathologic specimens were sent for frozen pathology according to the clock-wise method. Patients with confirmed cancer were arranged for conservative breast surgery. Of the 127 patients, 53 patients (41.7%) had gland hyperplasia; 7 had fibroadenoma (5.5%); 1 (0.79%) had ductal carcinoma in situ, who underwent breast conserving surgery, following by chemotherapy and radiotherapy, no relapse was noted during the three-year follow-up. Clock-wise method is useful to locate the tumor and ensure the patients to receive skin-spared breast resection even cancer is detected.